http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200088780-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9dc5556d4b0a048ee7a7e0306a46607 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-32 |
filingDate | 2020-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2144acc9a90b2de8ea4858619914c5a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92c147de239e2224ad64c255c3075bd1 |
publicationDate | 2020-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20200088780-A |
titleOfInvention | Enhanced cytosol-penetrating antibody |
abstract | The present invention relates to an antibody having enhanced cytoplasmic permeability, and to a cytoplasmic penetration antibody or an antigen-binding fragment thereof, comprising an amino acid variation in at least one selected from the group consisting of CDR1, FR and CDR3 among light chain variable regions. After cell-free protein synthesis, it was adopted as a screening method capable of evaluating cytoplasmic permeability without purification, and it was confirmed that the endosomal escape ability was improved and the antigen targeting ability was maintained. |
priorityDate | 2019-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 400.